NCT06271577 - Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions

Myocardial InfarctionIschemiaMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesHeart AttackHeart Failure

Interventions

DEVICE

AliveCor 12-lead ECG

The primary objective of this study is to determine if the AliveCor 12-lead Smartphone ECG is an acceptable substitute for a standard 12-lead ECG in the identification of STEMI and NSTEMI.

Trial Locations (2)

55905

RECRUITING

Mayo Clinic, Rochester

84107

RECRUITING

Intermountain Health, Murray